close

Agreements

1 2 3 4 5 242
Number of results: 4836

Excel print is not allowed for data more than 3000.Please search above for fewer data.

Date Company Compound Disease Type of agreement Therapeutic area Type of Information
2018-09-11 Amicus Therapeutics (USA - NJ) member of the board of directors nomination Rare diseases - Genetic diseases - Metabolic diseases Nomination
2018-09-10 Affilofic (France) Samabriva (France) Nanofitin®-conjugated biotherapeutics lysosomal storage disorders licensing Rare diseases - Genetic diseases - Metabolic diseases Licensing agreement
2018-09-10 Five Prime Therapeutics (USA - CA) SOLTI (Spain) Reolysin® (pelareorep - human reovirus type 3 Dearing strain) breast cancer clinical research Cancer - Oncology Clinical research agreement
2018-09-10 Pieris Pharmaceuticals (USA - MA) member of the board of directors nomination Cancer - Oncology Nomination
2018-09-10 Halozyme Therapeutics (USA - CA) member of the board of directors nomination Cancer - Oncology Nomination
2018-09-10 Glythera, now Iksuda Therapeutics (UK) restructuring - corporate name change Cancer - Oncology Restructuring
2018-09-10 Thrombogenics (Belgium) now Oxurion (Belgium) Ophtalmological diseases Restructuring
2018-09-10 Medivir (Sweden) chief medical officer nomination Nomination
2018-09-06 Leukocare (Germany) Xellia Pharmaceuticals (Denmark) new formulations for anti-infective products research - development - R&D Infectious diseases Research agreement
2018-09-06 Eli Lilly (USA - IN) Imperial College London (UK) UCL (UK) Process Systems Engineering (PSE) methods collaboration - research Technology - Services Research agreement
2018-09-06 Oncolytics Biotech (Canada) Roche (Switzerland) atezolizumab (Tecentriq®) collaboration - supply agreement Collaboration agreement
2018-09-04 Radius Health (USA - MA) chief medical officer nomination Bone diseases - Cancer - Oncology Nomination
2018-09-04 Ziopharm Oncology (USA - MA) member of the board of directors nomination Cancer - Oncology Nomination
2018-09-04 Tmunity Therapeutics, (USA - PA) executive vice-president nomination Cancer - Oncology Nomination
2018-08-30 Eli Lilly (USA - IN) senior vice president nomination Nomination
2018-08-28 SGS (Switzerland) construction of new premises Technology - Services Construction of new premises
2018-08-28 Allogene Therapeutics (USA - CA) senior vice president nomination Cancer - Oncology Nomination
2018-08-23 Bluebird bio (USA - MA) Gritstone Oncology (USA - CA) tumor-specific targets and natural T-cell receptors (TCRs) research - development - commercialisation Cancer - Oncology Research agreement
2018-08-16 BioNTech (Germany) Pfizer (USA - NY) mRNA-based flu vaccines influenza (flu) research - development - R&D Infectious diseases Development agreement
2018-08-14 Actavalon (USA - CA) member of the board of directors nomination Cancer - Oncology Nomination